BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18726607)

  • 1. Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature.
    Behtash N; Behnamfar F; Hamedi B; Ramezanzadeh F
    Arch Gynecol Obstet; 2009 Apr; 279(4):579-81. PubMed ID: 18726607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
    Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
    Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
    Bilgin T; Ozan H; Ozuysal S; Ozkan L
    Arch Gynecol Obstet; 2004 Jan; 269(2):159-60. PubMed ID: 14648186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal pregnancy after curative multiagent chemotherapy for choriocarcinoma with brain metastases.
    Bakri YN; Pedersen P; Nassar M
    Acta Obstet Gynecol Scand; 1991; 70(7-8):611-3. PubMed ID: 1785279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
    Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
    Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
    Xiang Y; Sun Z; Wan X; Yang X
    J Reprod Med; 2004 Jun; 49(6):443-6. PubMed ID: 15283051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in survival from choriocarcinoma in Harare.
    Spooner SF; Coulombier DM
    Cent Afr J Med; 1991 Aug; 37(8):229-34. PubMed ID: 1725504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
    Fechtig A; de Dycker RP; Schumacher T; Zajaczkowski T; Neumann RL
    Geburtshilfe Frauenheilkd; 1992 Apr; 52(4):235-8. PubMed ID: 1607119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presentation and management of post-partum choriocarcinoma.
    Dobson LS; Gillespie AM; Coleman RE; Hancock BW
    Br J Cancer; 1999 Mar; 79(9-10):1531-3. PubMed ID: 10188902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y; Wan XR; Sun ZJ; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental site trophoblastic tumor: an overview.
    Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; CantĂș MG
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic cerebral choriocarcinoma coexistent with a viable pregnancy.
    Dana A; Saldanha GJ; Doshi R; Rustin GJ
    Gynecol Oncol; 1996 Apr; 61(1):147-9. PubMed ID: 8626104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y; Yang X; Han S
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):97-100. PubMed ID: 11263207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of resistant gestational trophoblastic tumors.
    Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
    J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated Liposomal Doxorubicin Is an Active Agent for Chemotherapy-Resistant Choriocarcinoma: A Report of Two Cases.
    Popadiuk C; Power P
    J Reprod Med; 2016; 61(5-6):215-8. PubMed ID: 27424361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
    Hiramatsu Y; Masuyama H; Ishida M; Murakami K; Sakurai M
    Acta Med Okayama; 2005 Oct; 59(5):235-8. PubMed ID: 16286962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.